Nova Biomedical Corp
Waltham, MA Part of Advanced Instruments LLC
- UEI
- LCFDHTGXB5J3
- CAGE
- 1JU03
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Advanced Instruments LLC, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Norwood, MA
JHMHLB2KXPN9
-
Parent
Norwood, MA
JHMHLB2KXPN9
- SAM.gov registration date
- Physical address
- 200 Prospect St, Waltham, MA 02453, USA
- Website
- novabiomedical.com
- Founded
- 1976
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $924,683 |
| FY2025 | $764,710 |
| FY2024 | $1,245,624 |
| FY2023 | $991,670 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $474,821 | |
| 2 | Defense Health Agency | $218,531 | |
| 3 | Department of Health and Human Services | $113,650 | |
| 4 | Department of Justice | $101,161 | |
| 5 | Department of State | $16,520 |
Contract vehicles
Expired vehicles (1)
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Weems Design Studio, Inc. | 75N91024F00014 | $39,375 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Werfen USA LLC | Bedford, MA | 334516 Analytical Laboratory Instrument Manufacturing |
| Siemens Healthcare Diagnostics Inc. | Tarrytown, NY | 334516 Analytical Laboratory Instrument Manufacturing |
| Abbott Nutrition | Lake Bluff, IL | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Radiometer America, Inc. | Brea, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| US Customer Operations | Brea, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Nova Biomedical Corp, a wholly-owned division of foreign-owned Advanced Instruments LLC and a large for-profit manufacturer of point-of-care diagnostic equipment and in-vitro testing devices, supplies glucose meters, blood gas analyzers, electrolyte testing instruments, and associated consumables to federal healthcare agencies as a prime contractor competing in unrestricted, full-and-open federal procurements with no set-aside footprint. Headquartered in Waltham, Massachusetts, Nova Biomedical operates across 817 prime federal contract awards with a combined potential value of $22.9 million and $17 million in obligated dollars, spanning five decades of federal supply relationships since 1982.
Nova's customer base concentrates heavily in the Department of Veterans Affairs ecosystem, particularly through its VHA regional networks. The top-five customer agencies by potential value—VA VHA VISN 15 ($2.7 million across 20 awards), the Defense Health Agency ($1.9 million across 14 awards), the National Institute of Allergy and Infectious Diseases ($1.6 million across 8 awards), the Food and Drug Administration ($1.5 million across 17 awards), and VA VHA VISN 21 ($1.4 million across 6 awards)—account for 40 percent of combined potential value. By award count, Indian Health Service (27 awards), the Department of Veterans Affairs (24 awards), the Navy Bureau of Medicine and Surgery (24 awards), the Army Medical Command (24 awards), and VA VHA VISN 16 (23 awards) lead the distribution, collectively representing 15 percent of the 817-award portfolio. Recent representative work includes a $1.1 billion single-award indefinite-delivery contract ceiling from VA VISN 2 for glucose POC meters and supplies through September 2027, with five delivery orders totaling $318,720 issued on award date; a $843,657 five-year definitive contract from the Defense Health Agency for StatStrip testing supplies and monitors at Fort Sam Houston through December 2029; a $676,160 VA VISN 5 delivery order for blood gas analyzers and yearly reagents under GSA Multiple Award Schedule with base plus four option years through June 2027; and a $254,300 VA VISN 21 sole-source purchase order for StatStrip glucose strips, meter warranty, and four option years through March 2031, citing Nova's meters as the only products meeting all patient-population requirements.
Nova's federal work flows primarily through GSA Multiple Award Schedule task orders and blanket purchase agreements rather than standalone vehicle seats. The top-five parent vehicles are the Federal Supply Schedule GS24F1306C (98 task orders, $1.5 million combined potential value), the GSA Multiple Award Schedule (31 task orders, $2.2 million), Federal Supply Schedule GS00F2482A (22 task orders), Federal Supply Schedule V797P6579A (13 task orders), and Federal Supply Schedule GS00F03662 (9 task orders). Nova also holds single-award BPAs with VA VISN 16 ($209,820.96 ceiling for electrolyte and ionized calcium analyzers through September 2030) and the Defense Health Agency ($189,200 ceiling for glucometer supplies at Fort Eisenhower through September 2028).
Recent activity has been stable to slightly declining. Awards per year averaged 13 to 15 from 2022 through 2025, dropping to 12 in 2026. Thirteen awards carrying combined potential value of $1.8 million reach ultimate completion within the next twenty-four months, creating recompete exposure across VA regional networks and Defense Health Agency programs. Nova subcontracts minimally; the award portfolio shows only one sub award—a May 2025 sub to Weems Design Studio for NIAID VRC operational task-order service maintenance on BioProfile analyzers.
Nova's award portfolio concentrates in analytical laboratory instrument manufacturing (275 awards) and medical equipment and supplies wholesaling (32 awards), with secondary weight in in-vitro diagnostic substance manufacturing (18 awards) and surgical appliance and supplies manufacturing (14 awards). Federal procurement classification mirrors this: Medical and Surgical Instruments, Equipment, and Supplies (247 awards), Laboratory Equipment and Supplies (184 awards), Hospital Furniture, Equipment, Utensils, and Supplies (91 awards), In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (73 awards), and Chemical Analysis Instruments (70 awards). The vendor's core federal role is consumables and equipment supply to military, veteran, and federal health research facilities, with no program management, systems integration, or IT services presence in the recent award footprint.
Quick answers
Is Nova Biomedical Corp registered in SAM.gov?
Yes. Nova Biomedical Corp's SAM.gov registration is active through June 21, 2027.
Which contract vehicles does Nova Biomedical Corp hold?
Nova Biomedical Corp holds a place on 2 federal contract vehicles, including MAS.
How much has Nova Biomedical Corp received in federal contracts?
Federal contracts obligated $764,710 to Nova Biomedical Corp in fiscal year 2025 and $3,926,687 in fiscal years 2023 through 2027.
How does Nova Biomedical Corp rank among federal contractors?
Nova Biomedical Corp's parent company, Advanced Instruments LLC, ranked #50 in PSC 6550, #59 in NAICS 325413 and #63 in PSC J075 in FY2025.
What is Nova Biomedical Corp's most recent federal award?
Nova Biomedical Corp's most recent federal contract award is Glucose meters (36C24226N0804), from Veterans Integrated Service Network 2 (VHA), on September 30, 2026.
On GovTribe
See Nova Biomedical Corp's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors